Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, November 25, 2019

Hospitals to Test Music-Based mHealth Platform for Stroke Treatment

And why didn't your hospital already have a music protocol for your rehab? All it would have taken is earbuds and some downloadable music for your smartphone.  Is YOUR HOSPITAL THAT FUCKING INCOMPETENT?



Hospitals to Test Music-Based mHealth Platform for Stroke Treatment

Five rehab hospitals across the country will soon be testing a digital therapeutic platform that combines music with AI and mHealth sensors to help stroke survivors with walking problems.







Source: ThinkStock
By Eric Wicklund
- Five rehabilitation hospitals will be testing a telehealth platform for stroke treatment that integrates music with AI and mHealth sensors for guided therapy.
The hospitals will be testing a digital therapeutic device developed by Portland, ME-based MedRhythms, which is seeking US Food and Drug Administration approval for the service. The program will study the mHealth device’s impact on walking among a group of patients who have walking impairments as a result of a stroke.
“Right now, the MedRhythms digital therapeutic technology is a novel treatment for a subset of individuals that have few, if any, effective treatment options,” David Putrino, director of the Abilities Research Center (ARC) for the Department of Rehabilitation and Human Performance at the Mount Sinai Health System, said in a press release. “The mission of the ARC is to identify and validate novel technologies that have the potential to significantly enhance the rehabilitation of people who are recovering from brain injuries and neurological conditions, including chronic stroke.”





Putrino will lead the research project at New York-based Mount Sinai. Also participating in the study are the Shirley Ryan AbilityLab in Chicago, the Kessler Foundation in New Jersey and Spaulding Rehabilitation Hospital and the Boston University Neuromotor Recovery Laboratory, both in Boston.
“The digital therapeutics industry has the potential to transform rehabilitation and disrupt healthcare, and it is imperative for companies in this space to run full-scale, multisite RCTs like MedRhythms is doing,” Putrino added.
MedRhythms began as a digital therapy program launched out of Spaulding Rehab, part of the Partners HealthCare network, and has been building a portfolio of digital therapeutic treatments for treatment of neurological injury and disease, including Parkinson’s Disease and Multiple Sclerosis. The company is also looking to apply the treatment to senior care and fall prevention programs.
The company’s first and signature product is MedRhythms Stride, a digital health platform for stroke rehabilitation that focuses on Rhythmic Auditory Simulation (RAS). mHealth sensors attached to a patient’s feet gather gait parameters, which are then analyzed by a smartphone app that pairs the patient’s gait with music.
“Rhythm is the main driver of the interventions we have,” Owen McCarthy, the company’s president and founder, told mHealthIntelligence in a 2018 interview. “And it’s the type of thing we’re going to see more and more of in healthcare.”
This past June, the company announced a partnership with Health Catalyst’s new life sciences business to make its platform available to payers and providers looking for new ways to enhance stroke rehabilitation programs.
“This partnership comes at a crucial time in the digital therapeutics industry,” Carlos Rodarte, senior vice president of strategy and business development for the life sciences at Health Catalyst, said in a press release. “Several companies in this field have completed or are completing important trials demonstrating the significant clinical impact of true, validated and regulated digital therapeutics, paving the way for an entire new industry in digital health which has disruptive potential globally to deliver rapid, efficient therapies for patients with unmet needs.”

No comments:

Post a Comment